PacBio
Laboratory Equipment · Genomics & Genetic Testing

PacBio revenue, results and funding

PacBio filed revenue of $160M for 2025.

Data updated Nov 19, 2026 · Back to the company report
$160MRevenue, 2025
−$546.4MNet income, 2025

Results by year

YearRevenueNet incomeTotal assetsLANG_CR_S_M_TAX_PAIDLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_BUYBACKSLANG_CR_S_M_CAPEXLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASHLANG_CR_S_M_DEBTLANG_CR_S_M_ACQUISITIONS
2025$160M−$546.4M$784.1M$481k$318k–$2.7M$41.7M$97.3M−$553.9M$63.7M–$0
2024$154M−$309.9M$1.3B$256k$316k–$6.2M$71M$134.9M−$474.3M$55.4M–$0
2023$200.5M−$306.7M$1.7B$140k−$11.4M–$8.8M$72.1M$187.2M−$334.5M$179.9M–$102k
2022$128.3M−$314.2M$1.8B–$0–$16.8M$78.6M$193M−$307.2M$325.1M$896.7M$0
2021$130.5M−$181.2M$2B–−$93.6M–$5.9M$73.4M$112.9M−$210.4M$460.7M$896.1M–
2020$78.9M$29.4M$414M–––$1M$17.5M$64.2M−$104.4M$81.6M––
2019$90.9M−$84.1M$148M–––$2.8M$16.4M$59.6M−$100.5M$29.6M$15.9M–
2018$78.6M−$102.6M$170.3M–––$1.9M$23.2M$62.6M−$101M$18.8M$14.7M–
2017$93.5M−$92.2M$144.1M–––$10.4M$20.4M$65.3M−$89.8M$16.5M$13.6M–
2016$90.7M−$74.4M$137.9M–––$8.2M$19.6M$67.6M−$71.2M$16.8M$16.1M–
2015$92.8M−$31.7M$131.1M–––$3M$13.8M$60.4M−$29.1M$33.6M––
2014$60.6M−$66.2M$124.4M–––$1.6M$9.9M$48.2M−$62.9M$36.4M$14.1M–
2013$28.2M−$79.3M$136.2M–––$909k$9.9M$45.2M−$77.5M$26.4M$13.3M–
2012$26M−$94.5M$129.7M–––$1.7M$9.7M$47.6M−$94.3M$46.5M$2.6M–
2011$33.9M−$109.4M$218.3M–––$9.3M$12.4M$76.1M−$109.8M$58.9M$2.8M–
Sources: SEC

How to cite

PacBio, Financials. Alion, Nov 19, 2026. https://alion.io/company/pacbio/financials

.json · .md · CC BY-SA 4.0